AZR-MD-001 ointment/semi-solid drug

DRUG2 trials

Sponsors

Azura Ophthalmics

Conditions

Contact Lens DiscomfortMeibomian Gland Dysfunction

Phase 2

Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD)

CompletedNCT04314362

Azura OphthalmicsMeibomian Gland Dysfunction

Start: 2020-07-14End: 2021-01-06Updated: 2023-01-25

Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD)

CompletedNCT05548491

Azura OphthalmicsContact Lens Discomfort

Start: 2022-11-10End: 2023-10-13Updated: 2023-10-18